Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U W Schaefer

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
European Journal of Cancer & Clinical Oncology|November 1, 1987
Allogeneic bone marrow transplantation for acute leukaemia or chronic myeloid leukaemia in the fifth decade of lifeD W Beelen, K Quabeck, H K Mahmoud, et al.
British Journal of Haematology|February 13, 2001
Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?O Ringdén, M Labopin, N C Gorin, et al.
Lancet (London, England)|May 3, 2000
Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow TransplantationF Frassoni, M Labopin, R Powles, et al.
Bone Marrow Transplantation|August 6, 2003
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)A R Zander, N Kröger, M Schleuning, et al.
Annals of Hematology|September 14, 2000
Transplant activities in Germany in 1998--a survey facilitated by the National Registry for Hemopoietic Stem Cell TransplantationH D Ottinger, C Müller, N Schmitz, et al.
Blood|August 9, 2001
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCTJ W van Esser, B van der Holt, E Meijer, et al.
Bone Marrow Transplantation|July 23, 1998
Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemiaJ R Passweg, P A Rowlings, K A Atkinson, et al.
British Journal of Haematology|May 22, 2001
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centresG Gahrton, H Svensson, M Cavo, et al.
Deutsche Medizinische Wochenschrift (1946)|May 28, 1982
[Bone marrow transplantation for aplastic anaemia and acute leukaemia (author's transl)]U W Schaefer, C G Schmidt, U Rüther, et al.
Pathologie-Biologie|January 1, 1978
Bone marrow transplantation in acute leukemia [proceedings]U W Schaefer, J H Beyer, W R Boecker, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
European Journal of Cancer & Clinical Oncology|November 1, 1987
Allogeneic bone marrow transplantation for acute leukaemia or chronic myeloid leukaemia in the fifth decade of lifeD W Beelen, K Quabeck, H K Mahmoud, et al.
British Journal of Haematology|February 13, 2001
Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?O Ringdén, M Labopin, N C Gorin, et al.
Lancet (London, England)|May 3, 2000
Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow TransplantationF Frassoni, M Labopin, R Powles, et al.
Bone Marrow Transplantation|August 6, 2003
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)A R Zander, N Kröger, M Schleuning, et al.
Annals of Hematology|September 14, 2000
Transplant activities in Germany in 1998--a survey facilitated by the National Registry for Hemopoietic Stem Cell TransplantationH D Ottinger, C Müller, N Schmitz, et al.
Blood|August 9, 2001
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCTJ W van Esser, B van der Holt, E Meijer, et al.
Bone Marrow Transplantation|July 23, 1998
Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemiaJ R Passweg, P A Rowlings, K A Atkinson, et al.
British Journal of Haematology|May 22, 2001
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centresG Gahrton, H Svensson, M Cavo, et al.
Deutsche Medizinische Wochenschrift (1946)|May 28, 1982
[Bone marrow transplantation for aplastic anaemia and acute leukaemia (author's transl)]U W Schaefer, C G Schmidt, U Rüther, et al.
Pathologie-Biologie|January 1, 1978
Bone marrow transplantation in acute leukemia [proceedings]U W Schaefer, J H Beyer, W R Boecker, et al.
Pageof 15